• UFP Technologies posted net sales up 4.1% to $154.2 million for quarter ended March 31, 2026, driven by 5.9% growth in medical-market sales, partly offset by a 15% drop in non-medical markets.
• Gross margin edged up 0.3 percentage point to 28.8%, while SG&A climbed 12.3% to $21 million, lifting SG&A as a share of sales to 13.6%.
• Net interest expense narrowed to $1.7 million from $2.8 million on lower average debt.
• Net cash provided by operations was $3.2 million, reflecting $17.5 million of net income offset by a $15.7 million increase in receivables tied to higher March sales volume.
• Management said February 2026 cyber incident has not had a material impact to date; company also expects vendor credits in coming quarters tied to IEEPA tariff refunds and related supplier pass-throughs.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. UFP Technologies Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001628280-26-032825), on May 08, 2026, and is solely responsible for the information contained therein.